ranolazine has been researched along with Pulmonary Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| de Lima Conceição, MR; Leal-Silva, P; Roman-Campos, D; Teixeira-Fonseca, JL | 1 |
| Chan, SY; Forfia, P; Han, Y; Mazurek, JA; Park, MH; Ramani, G; Vaidya, A; Waxman, AB | 1 |
| Alemanni, M; Altomare, C; Barile, L; Cornaghi, L; Gobbi, M; Latini, R; Lucchetti, J; Mostacciuolo, G; Rizzetto, R; Rocchetti, M; Ronchi, C; Russo, I; Sala, L; Staszewsky, LI; Zambelli, V; Zaza, A | 1 |
| Belardinelli, L; Chi, L; Dhalla, AK; Hoyer, K; Liles, JT; Oliver, J | 1 |
| Fragakis, N; Gong, M; Li, G; Liu, T; Zhang, C; Zhang, Z | 1 |
| Farber, HW; Finch, KT; Stratton, EA | 1 |
1 trial(s) available for ranolazine and Pulmonary Hypertension
| Article | Year |
|---|---|
Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial.
Topics: Heart Failure; Humans; Hypertension, Pulmonary; Quality of Life; Ranolazine; Stroke Volume; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
5 other study(ies) available for ranolazine and Pulmonary Hypertension
| Article | Year |
|---|---|
Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline-induced pulmonary hypertension.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Heart Atria; Hypertension, Pulmonary; Monocrotaline; Ranolazine; Rats; Rats, Wistar | 2023 |
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Topics: Acetanilides; Animals; Calcium Signaling; Collagen; Disease Models, Animal; Fibrosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Membrane Potentials; Monocrotaline; Myocytes, Cardiac; Myosin Heavy Chains; Piperazines; Pulmonary Artery; Ranolazine; Rats; Rats, Sprague-Dawley; Sodium; Sodium Channel Blockers; Sodium Channels; Time Factors; Vascular Remodeling; Vascular Resistance; Ventricular Function, Right; Ventricular Remodeling | 2014 |
Ranolazine reduces remodeling of the right ventricle and provoked arrhythmias in rats with pulmonary hypertension.
Topics: Acetanilides; Animals; Arrhythmias, Cardiac; Collagen; Electrocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Pulmonary; In Vitro Techniques; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2015 |
Ranolazine as a novel therapy for pulmonary arterial hypertension.
Topics: Animals; Humans; Hypertension, Pulmonary; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vascular Resistance; Ventricular Dysfunction, Right | 2016 |
Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.
Topics: Aged; Cardiovascular Agents; Female; Heart Failure; Humans; Hypertension, Pulmonary; Male; Pilot Projects; Ranolazine; Stroke Volume | 2016 |